Last reviewed · How we verify
NCT07329374
Additional Effects of Ladder Drills and Jump Training in Taekwondo Players
NA trial testing Ladder drills in Sports Physical Therapy in 40 participants. Completed in 5 November 2025.
5 October 2025
Quick facts
| Lead sponsor | Riphah International University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 40 |
| Start date | 21 November 2024 |
| Primary completion | 5 October 2025 |
| Estimated completion | 5 November 2025 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Ladder drills
- Jump training
Conditions studied
- Sports Physical Therapy — all drugs for Sports Physical Therapy →
Sponsor
Riphah International University
Who can join
Adults 18 to 25, male only, with Sports Physical Therapy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A Randomized controlled trial will be conducted with sample size of 40 players divided into two groups of 20, 20 players in each. Players will undergo 18 training sessions in six weeks, and each week has three training sessions. Each session, including a 10-minute warm-up and a 10-minute cool down, with 60 minutes in duration. The training will start with low intensity for the first two weeks, then progress to moderate intensity for the next two weeks, and finally reach high intensity, to the individual's ability and physical endurance.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07329374
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sports Physical Therapy
Currently open trials in the same condition.
- NCT07072715 — Plyometrics vs PAPE Training in Football: Effects on Agility, Explosive Power and Speed · NA · active not recruiting
- NCT07025668 — The Effectiveness of Different Exercise Approaches in Biceps Brachii Long Head Tendinopathy · NA · recruiting
- NCT07139028 — Effects of Tibialis Anterior Resistance Training With Ladder Drills in Basketball Athletes · NA · active not recruiting
- NCT07128862 — Heavy-load Resistance Training With and Without Blood Flow Restriction Therapy in Athletes · NA · recruiting
- NCT06509711 — Comparative Effects Of Mud Based Plyometric Jump Training on Volleyball Players · NA · recruiting
Other Riphah International University trials
Trials by the same sponsor.
- NCT07579585 — Effects of Photobiomodulation in Hemophilia Patients. · NA · recruiting
- NCT07504276 — Tele-Rehabilitation vs Conventional Rehabilitation for Cognitive Improvement in Stroke Survivors. · NA · recruiting
- NCT07484477 — Sedentary Behavior Modification, Cardiopulmonary Function & QOL Post Cardiac Surgery Patients. · NA · not yet recruiting
- NCT07438587 — Comparative Effects of Cadence Training vs Elliptical Training in Cricketers · NA · not yet recruiting
- NCT07484399 — Comparing Effects of HIIT and MICT on Functional Mobility, Muscle Strength, and Quality of Life in Diabetic Patients · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07329374 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Riphah International University
- Last refreshed: 9 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07329374.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing